Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
BlackRock Future Health ETF(BMED)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BMED
11/06/2026: BMED (1-star) has a low Upturn Star Rating. Not recommended to BUY.
BlackRock Future Health ETF (BMED) provides active, thematic exposure to global companies leading innovation in healthcare, including biotechnology and health technology. Its main strengths include the expertise of the BlackRock management team and a strategic focus on future-oriented healthcare trends. Investors typically utilize BMED as a growth-oriented satellite holding to enhance portfolio exposure to medical innovation. Primary risks include high sector concentration, price volatility driven by R&D outcomes, and regulatory uncertainty. The ETF is best suited for long-term growth investors who understand the risks of specialized thematic investing and can tolerate significant market fluctuations.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The fund focuses on innovative healthcare companies with high growth potential, aligning well with growth-oriented investment goals. |
| Momentum investor | Strong fit while signal remains positive | It can be an effective vehicle for capturing momentum in specific healthcare innovation trends when the broader growth environment is supportive. |
| Value investor | Weak fit | The fund emphasizes growth and innovation, which often leads to higher valuation multiples rather than the value-focused metrics preferred by value investors. |
| Dividend/Income investor | Weak fit | The portfolio prioritizes capital appreciation over dividend yield, making it unsuitable for investors seeking current income. |
| Low-risk investor | Weak fit | The concentration in innovative and emerging healthcare companies results in higher volatility that is generally unsuitable for low-risk portfolios. |
Investor Profile
Ideal Investor Profile
The ideal investor is an individual or advisor seeking specialized, growth-oriented exposure to the evolving healthcare sector and is willing to accept higher volatility for potential long-term alpha.
Suitability
BMED is best suited for long-term investors using it as a satellite holding to complement a core, diversified portfolio, rather than for active traders or those seeking passive broad-market tracking.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | Thematic healthcare stocks often experience significant price swings based on clinical trial results and regulatory news. |
| Market risk | Medium / high | General equity market downturns can disproportionately impact high-growth thematic funds. |
| Concentration | Medium / high | Focusing on future healthcare limits diversification compared to a broad-market health index. |
| Tracking/expense | Medium | The active expense ratio is higher than passive alternatives, creating a performance hurdle. |
| Liquidity | Medium / high | Low trading volume can increase costs for investors when entering or exiting large positions. |
| Business/sector quality | Medium | Success is highly dependent on the execution and R&D outcomes of specific, sometimes speculative, healthcare companies. |
Risk Analysis
Volatility
BMED exhibits higher volatility than the broad healthcare sector due to its concentration in growth-oriented, innovative firms that are often subject to rapid price swings based on clinical or market news.
Market Risk
The fund is subject to significant equity market risk and sector-specific risks, including regulatory, political, and patent cliff risks that are inherent to the healthcare and biotechnology industries.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Sector | Global Healthcare Equities | 98 | The fund provides diversified exposure to innovative healthcare companies worldwide that are leading advancements in medical technology and patient care. |
| Cash/collateral | Cash and Cash Equivalents | 2 | A small cash position is maintained for liquidity needs and portfolio management activities. |
Analysis of Past Performance
Type ETF | Historic Profit 62.08% | Avg. Invested days 89 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | ETF Returns Performance  5.0 |
| Profits based on simulation | Last Close 11/06/2026 |
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.